Dmytro Vasylyev

Dmytro Vasylyev

Auto-generated profile, based on publicly available information

Dmytro Vasylyev

V.N. Karazin Kharkiv National University of the Ministry of Education and Science of Ukraine, Kharkiv, Ukraine

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2025 in The Journal of V. N. Karazin Kharkiv National University, Series "Medicine"
Verified
Journal Article
Open access
PDF file
Fedir HladkykhFedir Hladkykh
Fedir Hladkykh
ТLТ.і. Liadova
Т.і. Liadova
MMM.S. Matvieienko
M.S. Matvieienko
DVD.V. Vasylyev
D.V. Vasylyev
Background. Thermoregulation maintains a stable body temperature, which is essential for normal physiological function. Therapeutic hypothermia is effectively used for neuroprotection in stroke, traumatic brain injury, increased intracranial pressure, and other conditions. Brain cooling reduces cellular damage, limits necrosis, and improves brain function. The optimal timing and duration of therapy depend on the specific condition. Hypothermia has significant potential when combined with other treatment methods, particularly pharmacological strategies, to enhance neuroprotection outcomes. Purpose – to characterize the current understanding of the role of therapeutic hypothermia in neuroprotection in traumatic brain injury and ischemic stroke. Materials and Methods. The selection of publications was carried out using databases such as PubMed, Clinical Key, Cochrane Library, eBook Business Collection, and Google Scholar with keywords including hypothermia, neuroprotection, traumatic brain injury, ischemic stroke, among others. The literature search was conducted in three stages: first, identifying relevant publications; second, reviewing article abstracts; and third, analyzing full-text articles for inclusion criteria. Inclusion criteria comprised topic relevance, adherence to evidence-based medicine, and access to full-text articles. The review was prepared in accordance with PRISMA guidelines. Results. Selective brain cooling, applied for neuroprotection, holds significant potential in reducing neuronal damage in ischemic stroke and traumatic brain injury. This method decreases neuronal metabolic activity, enhances their survival under restricted blood supply, and reduces damage from oxidative stress and neurotoxicity. The use of transarterial cooling enables targeted brain cooling, effectively lowering temperature in affected regions without impairing the function of other organs. However, further clinical research is necessary to optimize therapeutic approaches and determine the most effective treatment protocols, ensuring long-term efficacy and safety. Conclusions. Therapeutic hypothermia, particularly selective brain cooling, reduces the metabolic demands of brain cells, mitigating ischemic and traumatic damage by decreasing oxidative stress, excitotoxicity, and inflammation. This method effectively reduces neuronal injury in ischemic stroke by limiting inflammation and oxidative stress; however, further studies are needed to refine optimal treatment conditions. Hypothermia may also support neuroplasticity in traumatic brain injuries, yet additional research is required to evaluate its full effectiveness.

1 June 2017
Verified
Journal Article
Closed access
DVDmytro Vasylyev
Dmytro Vasylyev
LCL Chernobay
L Chernobay
OVO Vasylieva
O Vasylieva
М(Мария (Mariia) Олейник (Oliinyk)
Мария (Mariia) Олейник (Oliinyk)
MVM Vashuk
M Vashuk

24 November 2025 in Karazin Journal of Immunology
Verified
Journal Article
Open access
PDF file
МCМ.о. Chyzh
М.о. Chyzh
DVD.V. Vasylyev
D.V. Vasylyev
ТLТ.і. Liadova
Т.і. Liadova
MMM.S. Matvieienko
M.S. Matvieienko
Fedir HladkykhFedir Hladkykh
Fedir Hladkykh
Koshurba IlliaKoshurba Illia
Koshurba Illia
Background. Understanding of current scientific advances in cardiac injury during ischemia/reperfusion, particularly the immunological mechanisms underlying inflammation in this condition, provides the basis for developing potential therapeutic strategies targeting specific components of this process in the treatment of ischemic myocardial damage. Purpose – to systematize and summarize contemporary scientific data on the key immunological mechanisms of inflammation in ischemic heart injury, and to outline pathogenetic pathways that may serve as potential targets for selective anti-inflammatory therapeutic interventions. Materials and Methods. A selection of publications was performed followed by systematic analysis using the databases PubMed (https://pubmed.ncbi.nlm.nih.gov/), Clinical Key Elsevier (https://www.clinicalkey.com), Cochrane Library (https://www.cochranelibrary.com/), eBook Business Collection (https://www.ebsco.com/), and Google Scholar (https://scholar.google.com/). These sources provided information on immunological mechanisms of inflammation in ischemic heart injury, the role of innate and adaptive immune cells, signaling pathways of inflammatory activation, and cytokine cascades. Results. Ischemia/reperfusion injury of the heart unfolds as a programmed sequence of immunopathological reactions. Damage-associated molecular patterns initiate cascades involving cellular and humoral components of both innate and adaptive immunity. Dysregulation of these processes influences the extent of myocardial injury during acute ischemia and reperfusion, particularly in the presence of the «no-reflow» phenomenon, and in subsequent scar formation and myocardial remodeling. Modulation of cellular and molecular mechanisms may represent a promising therapeutic target. Conclusions. Ischemia/reperfusion injury of the myocardium results from a complex sequence of immune events that determine the balance between tissue damage and repair. The combination of targeted immunomodulation with support of resolution mechanisms of inflammation constitutes a promising therapeutic strategy to reduce infarct-related injury and improve myocardial recovery.